142 related articles for article (PubMed ID: 1665417)
1. ESGAB breakpoint determination: temafloxacin.
Phillips I; Acar J; Baquero F; Bergan T; Forsgren A; Wiedemann B
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
[No Abstract] [Full Text] [Related]
2. Breakpoint determination: rufloxacin.
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):574-5. PubMed ID: 8404928
[No Abstract] [Full Text] [Related]
3. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
[No Abstract] [Full Text] [Related]
4. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of marbofloxacin in horses.
Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
[TBL] [Abstract][Full Text] [Related]
7. Sparfloxacin and other new fluoroquinolones.
Richard P; Gutmann L
J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749
[No Abstract] [Full Text] [Related]
8. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):12S-14S. PubMed ID: 1662881
[TBL] [Abstract][Full Text] [Related]
9. Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
Aarestrup FM; Jensen NE; Jorsal SE; Nielsen TK
Vet Rec; 2000 Jan; 146(3):76-8. PubMed ID: 10674696
[No Abstract] [Full Text] [Related]
10. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Symonds WT; Nix DE
Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
Cho N; Miyakawa Z; Kimura T; Shimizu A; Notake Y; Kunii K
Drugs; 1995; 49 Suppl 2():391-2. PubMed ID: 8549373
[No Abstract] [Full Text] [Related]
12. [New quinolones].
Kakeya H; Fukushima K; Saito A
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():542-8. PubMed ID: 17455678
[No Abstract] [Full Text] [Related]
13. Evaluation of the bactericidal activity of temafloxacin.
Jacobs MR
Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
[TBL] [Abstract][Full Text] [Related]
14. [Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology].
Matsuda S; Shimizu T; Cho N; Okada H
Jpn J Antibiot; 1993 Jun; 46(6):492-504. PubMed ID: 8395608
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
Barry AL; Jones RN
J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of anaerobic bacteria to temafloxacin.
Southern PM; Patel S
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S334. PubMed ID: 8391861
[No Abstract] [Full Text] [Related]
17. Penetration of temafloxacin into body tissues and fluids.
Sörgel F
Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
[TBL] [Abstract][Full Text] [Related]
18. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
Padeĭskaia EN; Iakovlev VP
Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
[No Abstract] [Full Text] [Related]
19. [Review [new antimicrobial agent series XLI]: lomefloxacin].
Soejima R; Matsumoto F
Jpn J Antibiot; 1991 Oct; 44(10):1045-60. PubMed ID: 1662290
[No Abstract] [Full Text] [Related]
20. Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.
Zabinski RA; Vance-Bryan K; Krinke AJ; Walker KJ; Moody JA; Rotschafer JC
Antimicrob Agents Chemother; 1993 Nov; 37(11):2454-8. PubMed ID: 8285633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
